US20040097983A1 - Constriction device including reinforced suture holes - Google Patents
Constriction device including reinforced suture holes Download PDFInfo
- Publication number
- US20040097983A1 US20040097983A1 US10/665,174 US66517403A US2004097983A1 US 20040097983 A1 US20040097983 A1 US 20040097983A1 US 66517403 A US66517403 A US 66517403A US 2004097983 A1 US2004097983 A1 US 2004097983A1
- Authority
- US
- United States
- Prior art keywords
- sleeve
- suture
- elastic material
- increased thickness
- suture holes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002787 reinforcement Effects 0.000 claims abstract description 22
- 239000013013 elastic material Substances 0.000 claims description 29
- 230000003014 reinforcing effect Effects 0.000 claims description 9
- 210000004072 lung Anatomy 0.000 description 61
- 210000001519 tissue Anatomy 0.000 description 60
- 238000000034 method Methods 0.000 description 20
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 14
- 239000000463 material Substances 0.000 description 12
- 210000000038 chest Anatomy 0.000 description 9
- 210000002345 respiratory system Anatomy 0.000 description 8
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 238000002271 resection Methods 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001050 pharmacotherapy Methods 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 230000009325 pulmonary function Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 206010014561 Emphysema Diseases 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 208000030507 AIDS Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 0 CCC(CC1)CC1C(*)CC* Chemical compound CCC(CC1)CC1C(*)CC* 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010041899 Stab wound Diseases 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000001008 atrial appendage Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940125388 beta agonist Drugs 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- -1 corticosteroids Chemical class 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229960001361 ipratropium bromide Drugs 0.000 description 1
- KEWHKYJURDBRMN-ZEODDXGYSA-M ipratropium bromide hydrate Chemical compound O.[Br-].O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 KEWHKYJURDBRMN-ZEODDXGYSA-M 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 230000005586 smoking cessation Effects 0.000 description 1
- 230000029547 smooth muscle hypertrophy Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000779 thoracic wall Anatomy 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
Definitions
- the present invention is generally directed to a constriction device that constricts body tissue.
- the present invention is more particularly directed to a constriction device that includes reinforced suture holes to permit a suture to maintain the constriction device from being dislodged from the constricted body tissue while protecting the integrity of the constriction device.
- Constriction devices have been contemplated for constricting body tissue. Such devices have been considered for use, for example, in tissue resection procedures and in treating pulmonary disease.
- COPD Chronic Obstructive Pulmonary Disease
- COPD ulcerative colitis
- COPD is a progressive disease and currently has no cure.
- Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
- Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled ⁇ -agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
- Lung transplantation is also an option.
- COPD is the most common diagnosis for which lung transplantation is considered.
- this consideration is given for only those with advanced COPD.
- lung transplant is far from being available to all patients.
- Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
- Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. AIDS patients can suffer from air leaks in their lungs. Air leaks in lungs can further be caused by a puncture from a broken rib or a stab wound.
- the invention disclosed and claimed in copending U.S. application Ser. No. 09/534,244, incorporated herein by reference, provides an improved therapy for treating COPD and air leaks in lungs.
- the therapy includes a constriction device which, when deployed on a lung, suppresses air leaks in the lung tissue without requiring any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung with the device, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
- the lung constriction device includes a jacket or sheath of flexible material configured to cover at least a portion of a lung.
- the jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket.
- the jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein.
- the lung constriction device is preferably formed of expandable, such as elastic, material for receiving the lung tissue while the device is in an expanded or enlarged condition, and then contractible about the lung portion upon release of the expanded condition for constricting the lung tissue.
- Devices and methods similar to those disclosed in U.S. application Ser. No. 09/534,244 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue other than lung tissue.
- Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue.
- Resection procedures may be required to treat cancer, organ damage, or organ disease, for example.
- U.S. application Ser. No. 09/534,244 also discloses and claims various methods and apparatus for deploying the constricting device on body tissue such as lung tissue.
- One apparatus and method contemplates mechanically expanding the device in a transverse dimension while physically pulling the tissue to be constricted into the device.
- Another method contemplates mounting the device over a vacuum chamber and pulling the tissue into the vacuum chamber by engaging the tissue with an opened end of the chamber and then drawing a vacuum in the chamber. This draws the tissue into the chamber. Then, the chamber is withdrawn from the device, leaving the tissue constricted in the device.
- a further method contemplates inserting the device into a vacuum chamber and sealing the opened end of the chamber to the device. The opened end of the chamber and the tissue are then brought into sealing engagement. A vacuum is next pulled in the chamber and the device to pull the tissue into the device and chamber. Once the tissue is within the device, the chamber is removed from over the device leaving the tissue constricted in the device.
- constriction devices may become dislodged due to the nature of the soft tissue on which they are deployed. More specifically, soft body tissue has a tendency to expand at the proximal end of the device causing longitudinal slippage of the device on the body tissue. This may eventually lead to the device slipping totally free from the tissue.
- One disclosed device includes a plurality of fixation elements on the inner surface of the sleeve that grasp the body tissue upon release of the sleeve from the expanded condition. More particularly, the fixation elements are adjacent to one of the opposed openings and arranged in a side-by-side relation to grasp the body tissue between adjacent fixation elements when the sleeve is released from the expanded condition.
- the fixation elements may be integral to the longitudinal-side wall or adhered to the inner surface of the sleeve. Still further, the inner surfaces of the fixation elements may have roughened surfaces to further assist in grasping the constricted body tissue.
- fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue, it is contemplated herein that other forms of fixation may be further employed alone or in combination with the above described fixation structures for maintaining the constriction device on the constricted body tissue.
- fixation structures are suturing.
- the present invention provides a constriction device that constricts body tissue, and which is configured to be sutured to constricted body tissue while protecting the integrity of the device.
- the device includes an elongated sleeve including at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition.
- the device further includes at least one suture hole that receives a suture to maintain the sleeve on the body tissue and a reinforcement structure about the at least one suture hole.
- the reinforcement structure may be an increased thickness of the sleeve about the at least one suture hole.
- the sleeve may include a plurality of suture holes and the increased thickness may be about each of the suture holes.
- the suture holes are distributed about the sleeve near to the at least one opened end.
- the increased thickness of the sleeve may be formed as a band circumscribing the sleeve with the sutures holes extending through the band.
- the increased thickness may further have a tapered cross-section for guiding a suture needle into the suture holes.
- the increased thickness may extend from the inner surface of the sleeve or from the outer surface of the sleeve.
- the reinforcement structure may alternatively be a layer of elastic material having a higher tear strength than the elastic material of the sleeve and which is disposed about each of the suture holes.
- the layer of elastic material may be a continuous band about the sleeve.
- the present invention further provides a constriction device that constricts body tissue.
- the device includes a generally cylindrical elastic sleeve including opposed opened ends and having a wall of substantially uniform thickness that receives body tissue therein to constrict the body tissue and at least one suture hole to receive a suture to maintain the sleeve on tissue constricted by the sleeve.
- the sleeve wall has an increased thickness, greater than the substantially uniform thickness, about the at least one suture hole.
- the present invention still further provides a constriction device that constricts body tissue, and including sleeve means formed of elastic material including at least one opened end for constricting body tissue received therein, suture hole means for receiving a suture to maintain the sleeve means on the body tissue, and suture hole reinforcing means about the suture hole means for reinforcing the suture hole means.
- FIG. 1 is a simplified sectional view of a thorax illustrating a respiratory system having a constricting device embodying the present invention deployed on a portion of a lung to effect lung volume reduction;
- FIG. 2 is a sectional view similar to FIG. 1 but illustrating the respiratory system after the constricted lung portion has been resectioned;
- FIG. 3 is a perspective view illustrating a constricting device embodying the present invention.
- FIG. 4 is a cross-sectional view of a suture hole of the device of FIG. 3 and a suture hole reinforcement structure embodying the present invention
- FIG. 5 is a perspective view of another constriction device embodying the present invention.
- FIG. 6 is a cross-sectional view of a suture hole of the device of FIG. 5 and a suture hole reinforcement structure configured in accordance with another embodiment of the present invention
- FIG. 7 is a perspective view of another constriction device embodying the present invention.
- FIG. 8 is a cross-sectional view of a suture hole of the constriction device of FIG. 7 and illustrating its reinforcing structure in accordance with a still further embodiment of the present invention.
- FIG. 1 it is a sectional view of a respiratory system 20 .
- the respiratory system 20 resides within the thorax 22 which occupies a space defined by the chest wall 24 and the diaphragm 26 .
- the respiratory system 20 includes the trachea 28 , the left mainstem bronchus 30 , the right mainstem bronchus 32 , and the bronchial branches 34 , 36 , 38 , 40 , and 42 .
- the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56 , 58 , and 60 .
- Each bronchial branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof.
- a healthy respiratory system has an arched or inwardly arcuate diaphragm 26 .
- the diaphragm 26 straightens to increase the volume of the thorax 22 .
- This causes a negative pressure within the thorax,
- the negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition.
- the diaphragm returns to its original arched condition to decrease the volume of the thorax.
- the decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
- FIG. 1 also shows a constriction device 70 embodying the present invention deployed on lobe 58 .
- the device 70 is configured as a sleeve or sheath formed of a sheet of elastic biocompatible material.
- the material may be formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example.
- the sleeve is preferably opened at both ends and may be generally cylindrical in configuration.
- the sleeve may be applied to the lung lobe while in an expanded condition. This may be accomplished by expanding the sleeve with a vacuum and then pulling the lung portion into the sleeve with the vacuum. When the lung portion is within the sleeve, the expansion of the device is released. With the expansion released, the sleeve is permitted to contract or collapse about the lung portion to constrict the lung portion.
- the device 70 may be employed, for example, to suppress air leakages in lungs. It may also find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue.
- the constriction device 70 is fixed on the constricted lung tissue by a suture 71 .
- the device 70 preferably includes at least one suture hole, and more preferably at least two suture holes.
- the suture holes are reinforced as will be described subsequently so that when the device is sutured to the lung tissue, neither the suture needle nor the suture tears or adversely affects the integrity of the device 70 .
- FIG. 2 shows the respiratory system 20 after the constricted lung portion has been resectioned.
- the device 70 is preferably formed of severable material, such as, any of the materials previously described. This enables the device 70 to be severed or cut intermediate its ends with a suitable bladed instrument to resection the lung lobe 58 . The portion of the device 70 remaining on the lobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. The suture 71 continues to maintain the device 70 on the remaining constricted tissue. Hence, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and avoiding the potentially severe complications which accompany such a procedure.
- FIG. 3 illustrates a constriction device 80 embodying the present invention.
- the device 80 is a generally cylindrical sleeve 81 having a longitudinal dimension 82 and a transverse dimension 84 .
- the device 80 is preferably formed of an elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension.
- the device 80 has opposed opened ends 86 and 88 .
- the device may further include at one end, for example, end 88 an integral rim 90 .
- the device 80 further includes a plurality of suture holes 92 .
- the suture holes 92 are preferably distributed about the device closely adjacent the opened end 88 .
- a suture hole reinforcement structure 94 about each suture hole 92 is a suture hole reinforcement structure 94 .
- the suture hole reinforcement structure 94 of each suture hole 92 is an increased thickness or thickened portion 96 in the sleeve wall 98 from the generally uniform thinner wall thickness 99 .
- the increased thickness extends outwardly from the outer surface 100 of the sleeve 81 to define a ring shaped structure about each suture hole 92 .
- the reinforcement structure 94 of each suture hole 92 defines a tapered surface 102 . The tapered surface serves to help guide a suture needle through its corresponding suture hole.
- the suture holes 92 may be preformed so as to initially extend through the sleeve.
- the suture holes may be defined by the reinforcement structures 94 and more particularly the tapered surfaces 102 without being preformed. This leaves the suture holes to be punched through during the suturing process. However, by virtue of the suture hole reinforcement structures, such punching through can be accomplished safely without damage to the device 80 .
- FIG. 5 illustrates another constriction device 110 embodying the present invention.
- the device 110 is a generally cylindrical sleeve 111 having a longitudinal dimension 112 and a transverse dimension 110 .
- the device 110 is preferably formed of an elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension.
- the device 110 has opposed opened ends 116 and 118 and an integral rim 120 and end 118 .
- the device 110 includes a plurality of suture holes 122 distributed about the sleeve 111 closely adjacent the opened end 118 .
- a suture hole reinforcement structure 124 is about each suture hole 122 .
- each reinforcement structure 124 is an increased thickness or thickened portion 126 in the sleeve wall 128 from the generally uniform wall thickness 129 .
- the increased thickness extends inwardly from the inner surface 130 of the sleeve 111 to define a ring shaped structure about each suture hole 122 .
- the reinforcement structure 124 of each suture hole 122 defines a tapered surface 132 . The tapered surface serves to help guide a suture needle through its corresponding suture hole.
- the suture holes may be preformed so as to initially extend through the sleeve.
- the suture holes may be defined by the reinforcement structures without being preformed. While this leaves the suture holes to be punched through during the suturing process, however, such punching through can be accomplished safely without damage to the device by virtue of the suture hole reinforcement structures.
- FIGS. 7 and 8 illustrate another constriction device 140 embodying the present invention.
- the device 140 again is a generally cylindrical sleeve 141 having opposed opened ends 142 and 144 . Adjacent the opened end 144 and extending about the sleeve is a continuous band 146 .
- the band 146 may be a thickened portion of the sleeve from its substantially uniform thickness 147 or preferably is an additional layer of elastic material but having a higher tear resistance than the material forming the sleeve 141 that is bonded to the sleeve 141 .
- the band includes a plurality of apertures 148 defining suture holes for the sleeve 141 .
- the apertures 148 include tapered surfaces 150 to guide a suture needle through the apertures and the sleeve.
- the suture holes are thus reinforced by the band 146 against tearing or the like by the suture or suture needle.
- the wall thickness of the sleeve 141 must be punched through by the suture needle passing through the suture holes 148 .
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Materials For Medical Uses (AREA)
Abstract
A constriction device that constricts body tissue is configured to be safely sutured to constricted body tissue. The device includes a generally cylindrical elastic sleeve including opposed opened ends and having a wall of substantially uniform thickness that receives body tissue therein to be constricted. The sleeve includes a plurality of suture holes to receive a suture to maintain the sleeve the tissue constricted by the sleeve. The sleeve includes a suture hole reinforcement structure, as for example an increased wall thickness, about each suture hole to permit the device to be sutured to constricted body tissue without damaging the device.
Description
- The present invention is generally directed to a constriction device that constricts body tissue. The present invention is more particularly directed to a constriction device that includes reinforced suture holes to permit a suture to maintain the constriction device from being dislodged from the constricted body tissue while protecting the integrity of the constriction device.
- Constriction devices have been contemplated for constricting body tissue. Such devices have been considered for use, for example, in tissue resection procedures and in treating pulmonary disease.
- Chronic Obstructive Pulmonary Disease (COPD) has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
- The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991 COPD was the fourth leading cause of death in the United States and had increased 33% since 1979.
- COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking up hill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time.
- COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
- The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
- Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled β-agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, Ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pheumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
- Lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
- About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the procedure was abandoned.
- The lung volume reduction surgery (LVRS) was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor due to the fact that Medicare stopped remitting for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life.
- Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
- The improvements in pulmonary function resulting from LVRS cannot be ignored. However, the surgery is very invasive and fraught with complications. Among the complications is the potential for lung air leaks. Lung tissue is very thin, and fragile hence difficult to suture together. After a lung portion is sectioned and removed, the remaining lung is most often restructured with suture staples. In about thirty percent (30%) of the cases, the difficulty with suturing lung tissue results in air leaks. Treatment for such air leaks depends upon their severity and often, in the most serious cases, requires further open chest surgery.
- Air leaks in lungs can be caused by other causes. With increasing age, a patient may develop a weakened section of lung which may then rupture due to an extreme pressure differential, such as may result from simply a hard sneeze. AIDS patients can suffer from air leaks in their lungs. Air leaks in lungs can further be caused by a puncture from a broken rib or a stab wound.
- The invention disclosed and claimed in copending U.S. application Ser. No. 09/534,244, incorporated herein by reference, provides an improved therapy for treating COPD and air leaks in lungs. The therapy includes a constriction device which, when deployed on a lung, suppresses air leaks in the lung tissue without requiring any suturing of the effected lung tissue. Still further, by constricting a large enough portion of a lung with the device, lung volume reduction with the concomitant improved pulmonary function may be obtained without the need for any suturing of lung tissue at all.
- The lung constriction device includes a jacket or sheath of flexible material configured to cover at least a portion of a lung. The jacket has a pair of opened ends to permit the lung portion to be drawn into the jacket. The jacket is dimensioned to constrict the lung portion after the lung portion is drawn therein. The lung constriction device is preferably formed of expandable, such as elastic, material for receiving the lung tissue while the device is in an expanded or enlarged condition, and then contractible about the lung portion upon release of the expanded condition for constricting the lung tissue.
- An important aspect of the device and method disclosed in U.S. application Ser. No. 09/534,244 is the ability to sever the constricting device intermediate its ends. This allows a significant portion of the constricted lung tissue to be removed altogether while permitting a portion of the constricting device to remain in the body for continued suppression of air leaks and maintenance of the remaining lung tissue integrity.
- Devices and methods similar to those disclosed in U.S. application Ser. No. 09/534,244 may be employed to advantage in other and different procedures such as in general resection procedures and for body tissue other than lung tissue. Resection procedures are commonly performed for such body tissue as, for example, atrial appendage tissue, ovarian tissue, gall bladder tissue, pancreatic tissue, appendix tissue and spleen tissue. Resection procedures may be required to treat cancer, organ damage, or organ disease, for example.
- U.S. application Ser. No. 09/534,244 also discloses and claims various methods and apparatus for deploying the constricting device on body tissue such as lung tissue. One apparatus and method contemplates mechanically expanding the device in a transverse dimension while physically pulling the tissue to be constricted into the device.
- Another method contemplates mounting the device over a vacuum chamber and pulling the tissue into the vacuum chamber by engaging the tissue with an opened end of the chamber and then drawing a vacuum in the chamber. This draws the tissue into the chamber. Then, the chamber is withdrawn from the device, leaving the tissue constricted in the device.
- A further method contemplates inserting the device into a vacuum chamber and sealing the opened end of the chamber to the device. The opened end of the chamber and the tissue are then brought into sealing engagement. A vacuum is next pulled in the chamber and the device to pull the tissue into the device and chamber. Once the tissue is within the device, the chamber is removed from over the device leaving the tissue constricted in the device.
- Although various methods and apparatus have been conceived for effectively deploying constriction devices on body tissue, the constriction devices, over time, may become dislodged due to the nature of the soft tissue on which they are deployed. More specifically, soft body tissue has a tendency to expand at the proximal end of the device causing longitudinal slippage of the device on the body tissue. This may eventually lead to the device slipping totally free from the tissue.
- To meet the needs for fixation, U.S. application Ser. No. 09/902,821, filed Jul. 10, 2001, and incorporated herein by reference, discloses and claims a constriction device having positive fixation structure for maintaining the constriction device deployed on the body tissue.
- One disclosed device includes a plurality of fixation elements on the inner surface of the sleeve that grasp the body tissue upon release of the sleeve from the expanded condition. More particularly, the fixation elements are adjacent to one of the opposed openings and arranged in a side-by-side relation to grasp the body tissue between adjacent fixation elements when the sleeve is released from the expanded condition. The fixation elements may be integral to the longitudinal-side wall or adhered to the inner surface of the sleeve. Still further, the inner surfaces of the fixation elements may have roughened surfaces to further assist in grasping the constricted body tissue.
- While the fixation structures disclosed and claimed in the aforementioned U.S. application Ser. No. 09/902,821 are believed to be sufficient alone for maintaining the constriction device on the constricted body tissue, it is contemplated herein that other forms of fixation may be further employed alone or in combination with the above described fixation structures for maintaining the constriction device on the constricted body tissue. One additional form of fixation widely practiced in the medical field is suturing.
- While suturing would appear to be an option, simply suturing the constriction device to the constricted body tissue would pose a number of problems. Such problems would arise because the material from which the constriction device is formed is relatively thin elastic material. The suturing of such material could easily cause tearing of the device by the suture. Moreover, the very act of puncturing the device material with a suture needle could readily cause tearing of the device material. Hence, there is a need in the art for a constriction device configured to permit the suturing of the device to constricted body tissue which is structured to protect against the tearing of the device material by either the suture or a suture needle. The present invention addresses that need. the device material by either the suture or a suture needle. The present invention addresses that need.
- The present invention provides a constriction device that constricts body tissue, and which is configured to be sutured to constricted body tissue while protecting the integrity of the device. The device includes an elongated sleeve including at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition. The device further includes at least one suture hole that receives a suture to maintain the sleeve on the body tissue and a reinforcement structure about the at least one suture hole.
- The reinforcement structure may be an increased thickness of the sleeve about the at least one suture hole. The sleeve may include a plurality of suture holes and the increased thickness may be about each of the suture holes.
- Preferably, the suture holes are distributed about the sleeve near to the at least one opened end.
- The increased thickness of the sleeve may be formed as a band circumscribing the sleeve with the sutures holes extending through the band. The increased thickness may further have a tapered cross-section for guiding a suture needle into the suture holes. The increased thickness may extend from the inner surface of the sleeve or from the outer surface of the sleeve.
- The reinforcement structure may alternatively be a layer of elastic material having a higher tear strength than the elastic material of the sleeve and which is disposed about each of the suture holes. The layer of elastic material may be a continuous band about the sleeve.
- In accordance with further aspects, the present invention further provides a constriction device that constricts body tissue. The device includes a generally cylindrical elastic sleeve including opposed opened ends and having a wall of substantially uniform thickness that receives body tissue therein to constrict the body tissue and at least one suture hole to receive a suture to maintain the sleeve on tissue constricted by the sleeve. The sleeve wall has an increased thickness, greater than the substantially uniform thickness, about the at least one suture hole.
- The present invention still further provides a constriction device that constricts body tissue, and including sleeve means formed of elastic material including at least one opened end for constricting body tissue received therein, suture hole means for receiving a suture to maintain the sleeve means on the body tissue, and suture hole reinforcing means about the suture hole means for reinforcing the suture hole means.
- The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like reference numerals identify identical elements, and wherein:
- FIG. 1 is a simplified sectional view of a thorax illustrating a respiratory system having a constricting device embodying the present invention deployed on a portion of a lung to effect lung volume reduction;
- FIG. 2 is a sectional view similar to FIG. 1 but illustrating the respiratory system after the constricted lung portion has been resectioned;
- FIG. 3 is a perspective view illustrating a constricting device embodying the present invention;
- FIG. 4 is a cross-sectional view of a suture hole of the device of FIG. 3 and a suture hole reinforcement structure embodying the present invention;
- FIG. 5 is a perspective view of another constriction device embodying the present invention;
- FIG. 6 is a cross-sectional view of a suture hole of the device of FIG. 5 and a suture hole reinforcement structure configured in accordance with another embodiment of the present invention;
- FIG. 7 is a perspective view of another constriction device embodying the present invention; and
- FIG. 8 is a cross-sectional view of a suture hole of the constriction device of FIG. 7 and illustrating its reinforcing structure in accordance with a still further embodiment of the present invention.
- Referring now to FIG. 1, it is a sectional view of a respiratory system20. The respiratory system 20 resides within the
thorax 22 which occupies a space defined by thechest wall 24 and thediaphragm 26. - The respiratory system20 includes the
trachea 28, the left mainstem bronchus 30, theright mainstem bronchus 32, and thebronchial branches left lung lobes right lung lobes - A healthy respiratory system has an arched or inwardly
arcuate diaphragm 26. As the individual inhales, thediaphragm 26 straightens to increase the volume of thethorax 22. This causes a negative pressure within the thorax, The negative pressure within the thorax in turn causes the lung lobes to fill with air to an inflated condition. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes. - FIG. 1 also shows a
constriction device 70 embodying the present invention deployed onlobe 58. Thedevice 70 is configured as a sleeve or sheath formed of a sheet of elastic biocompatible material. The material may be formed from silicone rubber, polyurethane, expanded polytetraflouroethylene, polyester and polyurethane, or nylon and polyurethane, for example. The sleeve is preferably opened at both ends and may be generally cylindrical in configuration. - The sleeve may be applied to the lung lobe while in an expanded condition. This may be accomplished by expanding the sleeve with a vacuum and then pulling the lung portion into the sleeve with the vacuum. When the lung portion is within the sleeve, the expansion of the device is released. With the expansion released, the sleeve is permitted to contract or collapse about the lung portion to constrict the lung portion.
- The
device 70 may be employed, for example, to suppress air leakages in lungs. It may also find use to advantage in constricting a lung portion suffering from COPD to simulate or achieve lung volume reduction. All of the beneficial effects of lung volume reduction surgery may be realized and, most importantly, without requiring suturing of lung tissue. In accordance with the present invention, theconstriction device 70 is fixed on the constricted lung tissue by asuture 71. To that end, thedevice 70 preferably includes at least one suture hole, and more preferably at least two suture holes. The suture holes are reinforced as will be described subsequently so that when the device is sutured to the lung tissue, neither the suture needle nor the suture tears or adversely affects the integrity of thedevice 70. - FIG. 2 shows the respiratory system20 after the constricted lung portion has been resectioned. The
device 70 is preferably formed of severable material, such as, any of the materials previously described. This enables thedevice 70 to be severed or cut intermediate its ends with a suitable bladed instrument to resection thelung lobe 58. The portion of thedevice 70 remaining on thelobe 58 continues to constrict the lung tissue therein to form an effective seal from leakage. Thesuture 71 continues to maintain thedevice 70 on the remaining constricted tissue. Hence, lung volume reduction is rendered an available treatment while negating the need of conventional lung sectioning and avoiding the potentially severe complications which accompany such a procedure. - FIG. 3 illustrates a
constriction device 80 embodying the present invention. Thedevice 80 is a generallycylindrical sleeve 81 having a longitudinal dimension 82 and atransverse dimension 84. As previously mentioned, thedevice 80 is preferably formed of an elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension. Thedevice 80 has opposed opened ends 86 and 88. The device may further include at one end, for example, end 88 an integral rim 90. - In accordance with the present invention, the
device 80 further includes a plurality of suture holes 92. The suture holes 92 are preferably distributed about the device closely adjacent the openedend 88. As may best be seen in FIG. 4, about eachsuture hole 92 is a suturehole reinforcement structure 94. In accordance with this embodiment, the suturehole reinforcement structure 94 of eachsuture hole 92 is an increased thickness or thickenedportion 96 in thesleeve wall 98 from the generally uniform thinner wall thickness 99. The increased thickness extends outwardly from theouter surface 100 of thesleeve 81 to define a ring shaped structure about eachsuture hole 92. As will further be noted in FIG. 4, thereinforcement structure 94 of eachsuture hole 92 defines atapered surface 102. The tapered surface serves to help guide a suture needle through its corresponding suture hole. - The suture holes92 may be preformed so as to initially extend through the sleeve. Alternatively, the suture holes may be defined by the
reinforcement structures 94 and more particularly the taperedsurfaces 102 without being preformed. This leaves the suture holes to be punched through during the suturing process. However, by virtue of the suture hole reinforcement structures, such punching through can be accomplished safely without damage to thedevice 80. - FIG. 5 illustrates another
constriction device 110 embodying the present invention. Again, thedevice 110 is a generally cylindrical sleeve 111 having alongitudinal dimension 112 and atransverse dimension 110. As previously mentioned, thedevice 110 is preferably formed of an elastic material permitting the device to expand in the longitudinal dimension and more importantly in the transverse dimension. Thedevice 110 has opposed opened ends 116 and 118 and anintegral rim 120 and end 118. - Like the device8 of FIG. 3, the
device 110 includes a plurality ofsuture holes 122 distributed about the sleeve 111 closely adjacent the openedend 118. About eachsuture hole 122 is a suturehole reinforcement structure 124. As best seen in FIG. 6, eachreinforcement structure 124 is an increased thickness or thickenedportion 126 in thesleeve wall 128 from the generallyuniform wall thickness 129. Here, however, the increased thickness extends inwardly from theinner surface 130 of the sleeve 111 to define a ring shaped structure about eachsuture hole 122. As will further be noted in FIG. 6, thereinforcement structure 124 of eachsuture hole 122 defines atapered surface 132. The tapered surface serves to help guide a suture needle through its corresponding suture hole. - Again the suture holes may be preformed so as to initially extend through the sleeve. Alternatively, the suture holes may be defined by the reinforcement structures without being preformed. While this leaves the suture holes to be punched through during the suturing process, however, such punching through can be accomplished safely without damage to the device by virtue of the suture hole reinforcement structures.
- FIGS. 7 and 8 illustrate another
constriction device 140 embodying the present invention. Thedevice 140 again is a generallycylindrical sleeve 141 having opposed opened ends 142 and 144. Adjacent the openedend 144 and extending about the sleeve is acontinuous band 146. Theband 146 may be a thickened portion of the sleeve from its substantially uniform thickness 147 or preferably is an additional layer of elastic material but having a higher tear resistance than the material forming thesleeve 141 that is bonded to thesleeve 141. The band includes a plurality ofapertures 148 defining suture holes for thesleeve 141. Theapertures 148 include taperedsurfaces 150 to guide a suture needle through the apertures and the sleeve. The suture holes are thus reinforced by theband 146 against tearing or the like by the suture or suture needle. Here, however, the wall thickness of thesleeve 141 must be punched through by the suture needle passing through the suture holes 148. - While the invention has been described by means of specific embodiments and applications thereof, it is understood that numerous modifications and variations could be made thereto by those skilled in the art without departing from the spirit and scope of the invention. It is therefore to be understood that within the scope of the claims, the invention may be practiced otherwise than as specifically described herein.
Claims (38)
1. A constriction device that constricts body tissue, the device comprising:
an elongated sleeve including at least one opened end and being formed from elastic material to receive, when in an expanded condition, body tissue to be constricted and to constrict the body tissue when released from the expanded condition;
at least one suture hole that receives a suture to maintain the sleeve on the body tissue; and
a reinforcement structure about the at least one suture hole.
2. The device of claim 1 wherein the reinforcement structure is an increased thickness of the sleeve about the at least one suture hole.
3. The device of claim 2 wherein the sleeve includes a plurality of suture holes and wherein the reinforcement structure is an increased thickness about each of the suture holes.
4. The device of claim 3 wherein the suture holes are distributed about the sleeve.
5. The device of claim 3 wherein the suture holes are distributed about the sleeve near to the at least one opened end.
6. The device of claim 3 wherein the increased thickness of the sleeve forms a band circumscribing the sleeve and wherein the suture holes extend through the band.
7. The device of claim 6 wherein the band is near to the at least one opened end.
8. The device of claim 1 wherein the reinforcement structure includes a tapered cross-section that guides a suture needle into the at least one suture hole.
9. The device of claim 2 wherein the sleeve has an inner surface and wherein the increased thickness extends from the inner surface of the sleeve.
10. The device of claim 2 wherein the sleeve has an outer surface and wherein the increased thickness extends from the outer surface.
11. The device of claim 1 wherein the reinforcement structure is a layer of elastic material having a higher tear strength than the elastic material of the sleeve.
12. The device of claim 1 including a plurality of suture holes extending through the sleeve and wherein the reinforcement structure is a layer of elastic material having a higher tear strength than the elastic material of the sleeve and about each of the suture holes.
13. The device of claim 12 wherein the layer of elastic material forms a continuous band about the sleeve.
14. A constriction device that constricts body tissue, the device comprising:
a generally cylindrical elastic sleeve including opposed opened ends and having a wall of substantially uniform thickness that receives body tissue therein to constrict the body tissue; and
at least one suture hole that receives a suture to maintain the sleeve on tissue constricted by the sleeve,
the sleeve wall having an increased thickness, greater than the substantially uniform thickness, about the at least one suture hole.
15. The device of claim 14 wherein the sleeve includes a plurality of suture holes and wherein the sleeve wall has an increased thickness, greater than the substantially uniform thickness, about each of the suture holes.
16. The device of claim 15 wherein the suture holes are distributed about the sleeve.
17. The device of claim 15 wherein the suture holes are distributed about the sleeve near one of the opposed opened ends.
18. The device of claim 14 wherein the increased thickness of the sleeve forms a band circumscribing the sleeve and wherein the suture holes extend through the band.
19. The device of claim 18 wherein the band is near to one of the opposed opened ends.
20. The device of claim 14 wherein the at least one suture hole includes a tapered cross-section that guides a suture needle into the at least one suture hole.
21. The device of claim 14 wherein the sleeve has an inner surface and wherein the increased thickness extends from the inner surface of the sleeve.
22. The device of claim 14 wherein the sleeve has an outer surface and wherein the increased thickness extends from the outer surface.
23. The device of claim 14 wherein the increased thickness is a layer of elastic material having a higher tear strength than the elastic material of the sleeve.
24. The device of claim 14 including a plurality of suture holes extending through the sleeve and wherein the increased thickness is a layer of elastic material having a higher tear strength than the elastic material of the sleeve and about each of the suture holes.
25. The device of claim 24 wherein the layer of elastic material forms a continuous band about the sleeve.
26. A constriction device that constricts body tissue, the device comprising:
sleeve means formed of elastic material including at least one opened end for constricting body tissue received therein;
suture hole means for receiving a suture to maintain the sleeve means on the body tissue; and
suture hole reinforcing means about the suture hole means for reinforcing the suture hole means.
27. The device of claim 26 wherein the reinforcing means comprises an increased thickness of the elastic material about the suture hole means.
28. The device of claim 27 wherein the device includes a plurality of suture holes and wherein the reinforcing means comprises an increased thickness of the elastic material about each of the suture holes.
29. The device of claim 28 wherein the suture holes are distributed about the sleeve.
30. The device of claim 28 wherein the suture holes are distributed about the sleeve near to the at least one opened end.
31. The device of claim 28 wherein the increased thickness of the elastic material forms a band circumscribing the sleeve means and wherein the suture holes extend through the band.
32. The device of claim 31 wherein the band is near to the at least one opened end.
33. The device of claim 26 wherein the suture holes include tapered cross-sections that guide a suture needle into the suture holes.
34. The device of claim 27 wherein the sleeve means has an inner surface and wherein the increased thickness extends from the inner surface of the sleeve means.
35. The device of claim 27 wherein the sleeve means has an outer surface and wherein the increased thickness extends from the outer surface of the sleeve means.
36. The device of claim 26 wherein the reinforcing means is a layer of elastic material having a higher tear strength than the elastic material of the sleeve means.
37. The device of claim 26 including a plurality of suture holes extending through the sleeve means and wherein the reinforcing means is a layer of elastic material having a higher tear strength than the elastic material of the sleeve and about each of the suture holes.
38. The device of claim 37 wherein the layer of elastic material forms a continuous band about the sleeve means.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/665,174 US20040097983A1 (en) | 2001-10-02 | 2003-09-17 | Constriction device including reinforced suture holes |
US11/403,542 US20060212051A1 (en) | 2001-10-02 | 2006-04-13 | Constriction device including reinforced suture holes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/969,949 US6632239B2 (en) | 2001-10-02 | 2001-10-02 | Constriction device including reinforced suture holes |
US10/665,174 US20040097983A1 (en) | 2001-10-02 | 2003-09-17 | Constriction device including reinforced suture holes |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/969,949 Continuation US6632239B2 (en) | 2001-10-02 | 2001-10-02 | Constriction device including reinforced suture holes |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/403,542 Continuation US20060212051A1 (en) | 2001-10-02 | 2006-04-13 | Constriction device including reinforced suture holes |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040097983A1 true US20040097983A1 (en) | 2004-05-20 |
Family
ID=25516217
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/969,949 Expired - Lifetime US6632239B2 (en) | 2001-10-02 | 2001-10-02 | Constriction device including reinforced suture holes |
US10/665,174 Abandoned US20040097983A1 (en) | 2001-10-02 | 2003-09-17 | Constriction device including reinforced suture holes |
US11/403,542 Abandoned US20060212051A1 (en) | 2001-10-02 | 2006-04-13 | Constriction device including reinforced suture holes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/969,949 Expired - Lifetime US6632239B2 (en) | 2001-10-02 | 2001-10-02 | Constriction device including reinforced suture holes |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/403,542 Abandoned US20060212051A1 (en) | 2001-10-02 | 2006-04-13 | Constriction device including reinforced suture holes |
Country Status (6)
Country | Link |
---|---|
US (3) | US6632239B2 (en) |
EP (1) | EP1435848A1 (en) |
JP (1) | JP2005504578A (en) |
AU (1) | AU2002362449B2 (en) |
CA (1) | CA2462635A1 (en) |
WO (1) | WO2003028560A1 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080188809A1 (en) * | 2003-05-07 | 2008-08-07 | Portaero, Inc. | Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis |
US20090205651A1 (en) * | 2008-02-19 | 2009-08-20 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US20110015653A1 (en) * | 2009-07-16 | 2011-01-20 | Michael Bogart | Apparatus and Method for Joining Similar or Dissimilar Suture Products |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
USRE45921E1 (en) | 2000-03-23 | 2016-03-15 | Spiration, Inc. | Tissue resection device, system, and method |
US10470839B2 (en) | 2016-06-02 | 2019-11-12 | Covidien Lp | Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line |
US20220054250A1 (en) * | 2018-04-12 | 2022-02-24 | Axogen Corporation | Tissue grafts with pre-made attachment points |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6997189B2 (en) * | 1998-06-05 | 2006-02-14 | Broncus Technologies, Inc. | Method for lung volume reduction |
US20080114394A1 (en) | 2001-04-24 | 2008-05-15 | Houser Russell A | Arteriotomy Closure Devices and Techniques |
US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
US8961541B2 (en) | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
US6491706B1 (en) * | 2001-07-10 | 2002-12-10 | Spiration, Inc. | Constriction device including fixation structure |
US20030050648A1 (en) | 2001-09-11 | 2003-03-13 | Spiration, Inc. | Removable lung reduction devices, systems, and methods |
US6632239B2 (en) | 2001-10-02 | 2003-10-14 | Spiration, Inc. | Constriction device including reinforced suture holes |
US6589161B2 (en) * | 2001-10-18 | 2003-07-08 | Spiration, Inc. | Constriction device including tear resistant structures |
US6592594B2 (en) | 2001-10-25 | 2003-07-15 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
US10098640B2 (en) | 2001-12-04 | 2018-10-16 | Atricure, Inc. | Left atrial appendage devices and methods |
US20050149069A1 (en) * | 2001-12-04 | 2005-07-07 | Bertolero Arthur A. | Left atrial appendage devices and methods |
US20030216769A1 (en) | 2002-05-17 | 2003-11-20 | Dillard David H. | Removable anchored lung volume reduction devices and methods |
US20030181922A1 (en) | 2002-03-20 | 2003-09-25 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US7338433B2 (en) | 2002-08-13 | 2008-03-04 | Allergan, Inc. | Remotely adjustable gastric banding method |
AU2003262871B2 (en) | 2002-08-28 | 2008-02-28 | Apollo Endosurgery, Inc. | Fatigue-resistant gastric banding device |
US7100616B2 (en) | 2003-04-08 | 2006-09-05 | Spiration, Inc. | Bronchoscopic lung volume reduction method |
US7533671B2 (en) | 2003-08-08 | 2009-05-19 | Spiration, Inc. | Bronchoscopic repair of air leaks in a lung |
EP1706044B1 (en) | 2004-01-23 | 2011-10-05 | Allergan, Inc. | Releasably-securable one-piece adjustable gastric band |
WO2005087147A1 (en) | 2004-03-08 | 2005-09-22 | Endoart S.A. | Closure system for tubular organs |
CA2569043C (en) | 2004-03-18 | 2010-08-17 | Allergan, Inc. | Apparatus and method for volume adjustment of intragastric balloons |
WO2005122870A2 (en) | 2004-06-14 | 2005-12-29 | Pneumrx, Inc. | Lung access device |
US7766891B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US7766938B2 (en) | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
WO2006058195A2 (en) | 2004-11-23 | 2006-06-01 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US8251888B2 (en) | 2005-04-13 | 2012-08-28 | Mitchell Steven Roslin | Artificial gastric valve |
US7798954B2 (en) | 2006-01-04 | 2010-09-21 | Allergan, Inc. | Hydraulic gastric band with collapsible reservoir |
US8043206B2 (en) | 2006-01-04 | 2011-10-25 | Allergan, Inc. | Self-regulating gastric band with pressure data processing |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US7691151B2 (en) | 2006-03-31 | 2010-04-06 | Spiration, Inc. | Articulable Anchor |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US20080283065A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung |
US20080295829A1 (en) * | 2007-05-30 | 2008-12-04 | Portaero, Inc. | Bridge element for lung implant |
US8632605B2 (en) | 2008-09-12 | 2014-01-21 | Pneumrx, Inc. | Elongated lung volume reduction devices, methods, and systems |
US8317677B2 (en) | 2008-10-06 | 2012-11-27 | Allergan, Inc. | Mechanical gastric band with cushions |
US20100185049A1 (en) | 2008-10-22 | 2010-07-22 | Allergan, Inc. | Dome and screw valves for remotely adjustable gastric banding systems |
US8468836B2 (en) | 2008-11-12 | 2013-06-25 | General Mills, Inc. | Portable thermoelectric cooling/heating unit and related merchandizing system |
JP5807970B2 (en) | 2009-04-09 | 2015-11-10 | カーディオバスキュラー テクノロジーズ、インク. | Tissue suturing device, transfer device and system, kit and method therefor |
CN104622599B (en) | 2009-05-18 | 2017-04-12 | 纽姆克斯股份有限公司 | Cross-sectional modification during deployment of an elongate lung volume reduction device |
WO2011021083A1 (en) * | 2009-08-17 | 2011-02-24 | PolyTouch Medical, Inc. | Articulating patch deployment device and method of use |
US8758221B2 (en) | 2010-02-24 | 2014-06-24 | Apollo Endosurgery, Inc. | Source reservoir with potential energy for remotely adjustable gastric banding system |
US8840541B2 (en) | 2010-02-25 | 2014-09-23 | Apollo Endosurgery, Inc. | Pressure sensing gastric banding system |
US9028394B2 (en) | 2010-04-29 | 2015-05-12 | Apollo Endosurgery, Inc. | Self-adjusting mechanical gastric band |
US9044298B2 (en) | 2010-04-29 | 2015-06-02 | Apollo Endosurgery, Inc. | Self-adjusting gastric band |
US20110270024A1 (en) | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band having various compliant components |
US20110270025A1 (en) | 2010-04-30 | 2011-11-03 | Allergan, Inc. | Remotely powered remotely adjustable gastric band system |
US8517915B2 (en) | 2010-06-10 | 2013-08-27 | Allergan, Inc. | Remotely adjustable gastric banding system |
US20120059216A1 (en) | 2010-09-07 | 2012-03-08 | Allergan, Inc. | Remotely adjustable gastric banding system |
US8961393B2 (en) | 2010-11-15 | 2015-02-24 | Apollo Endosurgery, Inc. | Gastric band devices and drive systems |
US8795241B2 (en) | 2011-05-13 | 2014-08-05 | Spiration, Inc. | Deployment catheter |
US8876694B2 (en) | 2011-12-07 | 2014-11-04 | Apollo Endosurgery, Inc. | Tube connector with a guiding tip |
US8961394B2 (en) | 2011-12-20 | 2015-02-24 | Apollo Endosurgery, Inc. | Self-sealing fluid joint for use with a gastric band |
USD708745S1 (en) * | 2013-03-05 | 2014-07-08 | Anchor Orthopedics Xt Inc. | Suture trap |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
US10413635B2 (en) * | 2015-08-17 | 2019-09-17 | Vivex Biomedical, Inc. | Umbilical cord transplant product |
US20200315776A1 (en) * | 2019-04-08 | 2020-10-08 | Lifecell Corporation | Composite tissue product anchor bolster for three-dimensional biologic scaffolds and related methods |
US11576666B2 (en) | 2019-10-04 | 2023-02-14 | Arthrex, Inc | Surgical constructs for tissue fixation and methods of tissue repairs |
Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4075959A (en) * | 1977-04-06 | 1978-02-28 | The Singer Company | Pneumatic thread and fiber feeding devices |
US4205282A (en) * | 1978-08-21 | 1980-05-27 | Westinghouse Electric Corp. | Phase shifting circuit element |
US4267839A (en) * | 1979-09-12 | 1981-05-19 | Repromed, Inc. | Surgical instrument for use in reversible sterilization or permanent occlusion procedures |
US4799311A (en) * | 1987-02-26 | 1989-01-24 | Matsutani Seisakusho Co., Ltd. | Apparatus for attaching suture to surgical needle |
US4881939A (en) * | 1985-02-19 | 1989-11-21 | The Johns Hopkins University | Implantable helical cuff |
US5127412A (en) * | 1990-03-14 | 1992-07-07 | Cosmetto Aristodeme J | Skin tensioning |
US5226429A (en) * | 1991-06-20 | 1993-07-13 | Inamed Development Co. | Laparoscopic gastric band and method |
US5503638A (en) * | 1994-02-10 | 1996-04-02 | Bio-Vascular, Inc. | Soft tissue stapling buttress |
US5513652A (en) * | 1992-07-13 | 1996-05-07 | Schwartz; Alan N. | Male erection facilitation sheaths and methods of using same |
US5593413A (en) * | 1990-05-14 | 1997-01-14 | Medisys Technologies, Inc. | Device for assisting childbirth |
US5681271A (en) * | 1995-09-25 | 1997-10-28 | Nelson; Ronald E. | Ankle brace with relief |
US5769892A (en) * | 1996-10-22 | 1998-06-23 | Mitroflow International Inc. | Surgical stapler sleeve for reinforcing staple lines |
US5810855A (en) * | 1995-07-21 | 1998-09-22 | Gore Enterprise Holdings, Inc. | Endoscopic device and method for reinforcing surgical staples |
US5870779A (en) * | 1998-02-05 | 1999-02-16 | Heron; Rodney | Undergarment with a testicle pouch and genital space |
US5902312A (en) * | 1995-07-03 | 1999-05-11 | Frater; Dirk A. | System for mounting bolster material on tissue staplers |
US6036698A (en) * | 1998-10-30 | 2000-03-14 | Vivant Medical, Inc. | Expandable ring percutaneous tissue removal device |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6193648B1 (en) * | 1999-09-21 | 2001-02-27 | Acorn Cardiovascular, Inc. | Cardiac constraint with draw string tensioning |
US6230714B1 (en) * | 1998-11-18 | 2001-05-15 | Acorn Cardiovascular, Inc. | Cardiac constraint with prior venus occlusion methods |
US6298496B1 (en) * | 2000-04-18 | 2001-10-09 | Idamae Francesina Evans | Protective surgical sock (feet) protective surgical covering for the arm, hand |
US6308709B1 (en) * | 2000-11-22 | 2001-10-30 | Robert M. Paul | Erection-facilitating condom |
US6425856B1 (en) * | 2000-05-10 | 2002-07-30 | Acorn Cardiovascular, Inc. | Cardiac disease treatment and device |
US6491706B1 (en) * | 2001-07-10 | 2002-12-10 | Spiration, Inc. | Constriction device including fixation structure |
US6620095B2 (en) * | 2000-12-22 | 2003-09-16 | Syde A. Taheri | Cradle-assisted myocardial repair and treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4204282A (en) * | 1978-05-08 | 1980-05-27 | Bolt Richard A | Implantable artificial sphincter |
DE3582940D1 (en) * | 1984-01-25 | 1991-07-04 | Hahn Meitner Inst Berlin Gmbh | METHOD FOR PRODUCING SEMICONDUCTIVE MATERIALS AND / OR SEMICONDUCTOR COMPONENTS. |
FR2737442A1 (en) * | 1995-07-31 | 1997-02-07 | Michelin & Cie | TIRE WITH REINFORCED SADDLES |
FR2773702B1 (en) | 1998-01-16 | 2000-04-07 | Johnson & Johnson Internationa | COMPRESSION DEVICE FOR HEMOSTASIS OF AN ORGAN, SUCH AS LIVER |
ES2272225T3 (en) | 1999-08-24 | 2007-05-01 | Spiration, Inc. | LUNG VOLUME REDUCTION KIT. |
US6632239B2 (en) | 2001-10-02 | 2003-10-14 | Spiration, Inc. | Constriction device including reinforced suture holes |
-
2001
- 2001-10-02 US US09/969,949 patent/US6632239B2/en not_active Expired - Lifetime
-
2002
- 2002-10-01 CA CA002462635A patent/CA2462635A1/en not_active Abandoned
- 2002-10-01 EP EP02800456A patent/EP1435848A1/en not_active Withdrawn
- 2002-10-01 AU AU2002362449A patent/AU2002362449B2/en not_active Ceased
- 2002-10-01 JP JP2003531901A patent/JP2005504578A/en not_active Withdrawn
- 2002-10-01 WO PCT/US2002/031522 patent/WO2003028560A1/en active Application Filing
-
2003
- 2003-09-17 US US10/665,174 patent/US20040097983A1/en not_active Abandoned
-
2006
- 2006-04-13 US US11/403,542 patent/US20060212051A1/en not_active Abandoned
Patent Citations (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4075959A (en) * | 1977-04-06 | 1978-02-28 | The Singer Company | Pneumatic thread and fiber feeding devices |
US4205282A (en) * | 1978-08-21 | 1980-05-27 | Westinghouse Electric Corp. | Phase shifting circuit element |
US4267839A (en) * | 1979-09-12 | 1981-05-19 | Repromed, Inc. | Surgical instrument for use in reversible sterilization or permanent occlusion procedures |
US4881939A (en) * | 1985-02-19 | 1989-11-21 | The Johns Hopkins University | Implantable helical cuff |
US4799311A (en) * | 1987-02-26 | 1989-01-24 | Matsutani Seisakusho Co., Ltd. | Apparatus for attaching suture to surgical needle |
US5127412A (en) * | 1990-03-14 | 1992-07-07 | Cosmetto Aristodeme J | Skin tensioning |
US5593413A (en) * | 1990-05-14 | 1997-01-14 | Medisys Technologies, Inc. | Device for assisting childbirth |
US5226429A (en) * | 1991-06-20 | 1993-07-13 | Inamed Development Co. | Laparoscopic gastric band and method |
US5513652A (en) * | 1992-07-13 | 1996-05-07 | Schwartz; Alan N. | Male erection facilitation sheaths and methods of using same |
US5503638A (en) * | 1994-02-10 | 1996-04-02 | Bio-Vascular, Inc. | Soft tissue stapling buttress |
US5902312A (en) * | 1995-07-03 | 1999-05-11 | Frater; Dirk A. | System for mounting bolster material on tissue staplers |
US5810855A (en) * | 1995-07-21 | 1998-09-22 | Gore Enterprise Holdings, Inc. | Endoscopic device and method for reinforcing surgical staples |
US5681271A (en) * | 1995-09-25 | 1997-10-28 | Nelson; Ronald E. | Ankle brace with relief |
US5769892A (en) * | 1996-10-22 | 1998-06-23 | Mitroflow International Inc. | Surgical stapler sleeve for reinforcing staple lines |
US5870779A (en) * | 1998-02-05 | 1999-02-16 | Heron; Rodney | Undergarment with a testicle pouch and genital space |
US6077214A (en) * | 1998-07-29 | 2000-06-20 | Myocor, Inc. | Stress reduction apparatus and method |
US6036698A (en) * | 1998-10-30 | 2000-03-14 | Vivant Medical, Inc. | Expandable ring percutaneous tissue removal device |
US6230714B1 (en) * | 1998-11-18 | 2001-05-15 | Acorn Cardiovascular, Inc. | Cardiac constraint with prior venus occlusion methods |
US6193648B1 (en) * | 1999-09-21 | 2001-02-27 | Acorn Cardiovascular, Inc. | Cardiac constraint with draw string tensioning |
US6298496B1 (en) * | 2000-04-18 | 2001-10-09 | Idamae Francesina Evans | Protective surgical sock (feet) protective surgical covering for the arm, hand |
US6425856B1 (en) * | 2000-05-10 | 2002-07-30 | Acorn Cardiovascular, Inc. | Cardiac disease treatment and device |
US6308709B1 (en) * | 2000-11-22 | 2001-10-30 | Robert M. Paul | Erection-facilitating condom |
US6620095B2 (en) * | 2000-12-22 | 2003-09-16 | Syde A. Taheri | Cradle-assisted myocardial repair and treatment |
US6491706B1 (en) * | 2001-07-10 | 2002-12-10 | Spiration, Inc. | Constriction device including fixation structure |
Cited By (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45921E1 (en) | 2000-03-23 | 2016-03-15 | Spiration, Inc. | Tissue resection device, system, and method |
US8029492B2 (en) | 2003-05-07 | 2011-10-04 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US20080188809A1 (en) * | 2003-05-07 | 2008-08-07 | Portaero, Inc. | Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis |
US7828789B2 (en) | 2003-05-07 | 2010-11-09 | Portaero, Inc. | Device and method for creating a localized pleurodesis and treating a lung through the localized pleurodesis |
US7789083B2 (en) | 2003-05-20 | 2010-09-07 | Portaero, Inc. | Intra/extra thoracic system for ameliorating a symptom of chronic obstructive pulmonary disease |
US7896008B2 (en) | 2003-06-03 | 2011-03-01 | Portaero, Inc. | Lung reduction system |
US7753052B2 (en) | 2003-06-05 | 2010-07-13 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system |
US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
US8323230B2 (en) | 2003-07-15 | 2012-12-04 | Portaero, Inc. | Methods and devices to accelerate wound healing in thoracic anastomosis applications |
US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US7726305B2 (en) | 2006-01-17 | 2010-06-01 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7686013B2 (en) | 2006-01-17 | 2010-03-30 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve |
US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US8252003B2 (en) | 2008-02-19 | 2012-08-28 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US8453637B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | Pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US7927324B2 (en) | 2008-02-19 | 2011-04-19 | Portaero, Inc. | Aspirator and method for pneumostoma management |
US8231581B2 (en) | 2008-02-19 | 2012-07-31 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US7909803B2 (en) | 2008-02-19 | 2011-03-22 | Portaero, Inc. | Enhanced pneumostoma management device and methods for treatment of chronic obstructive pulmonary disease |
US20090205651A1 (en) * | 2008-02-19 | 2009-08-20 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US8347880B2 (en) | 2008-02-19 | 2013-01-08 | Potaero, Inc. | Pneumostoma management system with secretion management features for treatment of chronic obstructive pulmonary disease |
US8506577B2 (en) | 2008-02-19 | 2013-08-13 | Portaero, Inc. | Two-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8348906B2 (en) | 2008-02-19 | 2013-01-08 | Portaero, Inc. | Aspirator for pneumostoma management |
US8365722B2 (en) | 2008-02-19 | 2013-02-05 | Portaero, Inc. | Multi-layer pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8430094B2 (en) | 2008-02-19 | 2013-04-30 | Portaero, Inc. | Flexible pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8453638B2 (en) | 2008-02-19 | 2013-06-04 | Portaero, Inc. | One-piece pneumostoma management system and methods for treatment of chronic obstructive pulmonary disease |
US8021320B2 (en) | 2008-02-19 | 2011-09-20 | Portaero, Inc. | Self-sealing device and method for delivery of a therapeutic agent through a pneumostoma |
US8464708B2 (en) | 2008-02-19 | 2013-06-18 | Portaero, Inc. | Pneumostoma management system having a cosmetic and/or protective cover |
US8474449B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Variable length pneumostoma management system for treatment of chronic obstructive pulmonary disease |
US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8491602B2 (en) | 2008-02-19 | 2013-07-23 | Portaero, Inc. | Single-phase surgical procedure for creating a pneumostoma to treat chronic obstructive pulmonary disease |
US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US8517073B2 (en) | 2009-07-16 | 2013-08-27 | Covidien Lp | Apparatus and method for joining similar or dissimilar suture products |
US9095335B2 (en) | 2009-07-16 | 2015-08-04 | Covidien Lp | Apparatus and method for joining similar or dissimilar suture products |
US20110015653A1 (en) * | 2009-07-16 | 2011-01-20 | Michael Bogart | Apparatus and Method for Joining Similar or Dissimilar Suture Products |
US10470839B2 (en) | 2016-06-02 | 2019-11-12 | Covidien Lp | Assessment of suture or staple line integrity and localization of potential tissue defects along the suture or staple line |
US20220054250A1 (en) * | 2018-04-12 | 2022-02-24 | Axogen Corporation | Tissue grafts with pre-made attachment points |
US11980536B2 (en) * | 2018-04-12 | 2024-05-14 | Axogen Corporation | Tissue grafts with pre-made attachment points |
Also Published As
Publication number | Publication date |
---|---|
CA2462635A1 (en) | 2003-04-10 |
EP1435848A1 (en) | 2004-07-14 |
WO2003028560A9 (en) | 2004-05-06 |
WO2003028560A1 (en) | 2003-04-10 |
JP2005504578A (en) | 2005-02-17 |
US20030065339A1 (en) | 2003-04-03 |
US6632239B2 (en) | 2003-10-14 |
AU2002362449B2 (en) | 2008-04-24 |
US20060212051A1 (en) | 2006-09-21 |
AU2002362449A2 (en) | 2003-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6632239B2 (en) | Constriction device including reinforced suture holes | |
US6589161B2 (en) | Constriction device including tear resistant structures | |
AU2002362449A1 (en) | Constriction device including reinforced suture holes | |
EP1078601B1 (en) | Kit for lung volume reduction | |
US6491706B1 (en) | Constriction device including fixation structure | |
AU2002353813A1 (en) | Constriction device including tear resistant structures | |
US6328689B1 (en) | Lung constriction apparatus and method | |
US6860847B2 (en) | Constriction device viewable under X ray fluoroscopy | |
EP1437971A1 (en) | Bronchial obstruction device deployment system and method | |
AU2002329218A1 (en) | Constriction device including fixation structure | |
AU2002354640A1 (en) | Construction device viewable under X ray fluoroscopy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: GYRUS ACMI, INC., MASSACHUSETTS Free format text: MERGER;ASSIGNOR:SPIRATION, INC.;REEL/FRAME:052401/0484 Effective date: 20200401 |